GlassScriptPhysician profile
Arthur Lawrence Smith
NPI 1629000856
$616.70
in general payments reported to CMS, 2019-2025
9 companies · $19.63 in 2025
The $19.63 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.54 · 2020: $63.59 · 2021: $84.50 · 2022: $110 · 2023: $97.64 · 2024: $218 · 2025: $19.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $218 · Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $217.82 |
| Food and Beverage | $117.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $346.74 | 2019-2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $95.51 | 2022-2025 | Ubrelvy |
| Novartis Pharmaceuticals Corporation | $38.26 | 2021 | |
| Sunovion Pharmaceuticals INC. | $34.00 | 2022 | |
| Lilly USA, LLC | $31.92 | 2022-2023 | Emgality, Reyvow |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Allergan, INC. | $18.01 | 2020 | |
| Celgene Corporation | $11.66 | 2021 | |
| Supernus Pharmaceuticals, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.